The Patent Finder

Terms ending in 2035

AbbVie Inc.

Every in-force patent on AbbVie Inc.'s record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,333,204Solid Antiviral Dosage Forms
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,744,170Solid Antiviral Dosage Forms
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 10,105,365Solid Antiviral Dosage Forms
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 10,118,958Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 12,098,189Composition and Method for the Diagnosis and Treatment of Iron-Related Disorders
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,777,020FURO-3-Carboxamide Derivatives and Methods of Use
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 9,464,082Aryl and Arylalkyl Substituted Pyrazolyl and Pyrimidinyl Tricyclic Enones as Antioxidant Inflammation Modulators
In force
 · High confidence
Reata Pharmaceuticals, Inc.In forceHigh confidence
US 9,382,247Novel Salts and Pharmaceutical Compositions Thereof for the Treatment of Inflammatory Disorders
In force
 · High confidence
Alfasigma S.P.A.In forceHigh confidence
US 9,452,9866-Heteroaryloxy- or 6-Aryloxy-QUINOLINE-2-Carboxamides and Method of Use
In force
 · High confidence
AbbVie Inc.In forceHigh confidence
US 10,493,158Pharmaceutical Compositions for the Treatment of Inflammatory Disorders
In force
 · High confidence
Alfasigma S.P.A.In forceHigh confidence
41 more term ends in 2035 · Pro
10 of 51 patents shown. Soonest term end first, then patent number.
Pro members see all 51.
Upgrade to Pro
44 of these are in force and held by AbbVie Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited